Study Expands on Vagus Nerve Stimulation for Depression
April 1st 2001In response to encouraging results from a small pilot study of vagus nerve stimulation (VNS) for treatment-resistant depression, researchers are now expanding the study to approximately 200 patients in 20 sites across the United States.
New Products, Applications Assessed at NCDEU
March 1st 2001Evaluations of new drugs, new dosage formulations and new applications for currently approved drugs were a substantial portion of the scientific program at the 40th annual NCDEU meeting, which is sponsored by the National Institute of Mental Health.
APA Annual Meeting Highlights New Research
March 1st 2001(The following are highlights of new research presented at the 2000 American Psychiatric Association Annual Meeting. Additional highlights can be found in "APA Meeting Highlights New Research," in the February issue of Psychiatric Times, p23-Ed.)
Gender Bias in Psychiatric Textbooks
March 1st 2001There is a history of gender bias in medical education and practice. Research has shown that this bias extends to the psychiatric field as well. Through material presented to medical trainees-in classes, textbooks, research reviews and the like-subsequent thoughts and actions may be negatively biased against women. A review of the ways in which biases are conveyed is explored, as well as suggestions for reducing, eliminating and preventing these biases in medical education.
APA Meeting Highlights New Research
February 1st 2001Because there is intense pressure by managed care to shorten the hospital stay for patients with anorexia nervosa, there is a need for partial-hospitalization treatment programs. Since patients gain an average of 0.5 lbs/week to 1.5 lbs/week in these less-monitored programs, as opposed to 2 lbs/week to 3 lbs/week in the inpatient behavioral specialty programs, Angela S. Guarda, M.D., and colleagues (Symposium 21B) described components that would improve the partial treatment program.
The Domestication of the Truth
February 1st 2001Two studies of patients who switched from Clozaril to generic clozapine are being evaluated by the U.S. Food and Drug Administration to determine whether the rating of the generic drug as bioequivalent (AB) to the brand-reference drug should be reconsidered and whether additional bioavailability assessment should be undertaken.
Is Pathological Gambling Really a Problem?-You Bet!
February 1st 2001With more and more Americans engaging in gambling activities, odds are high that psychiatrists may see patients who have some sort of gambling problem. What can be done about this problem, and how can these patients best be treated?
Trying To Solve the Prescription Drug Abuse Equation
February 1st 2001Results from the 1999 National Household Survey on Drug Abuse show significant increases in rates of prescription drug abuse. Other surveys show similar findings. An overview of the most commonly abused drugs and suggestions for preventing abuse are reviewed.
Addiction and the Eating Disorders
February 1st 2001Although comprehensive theories of addiction recognize the etiological importance of environmental and cognitive factors, it has been widely accepted for many years that addiction is also a brain disease and that individuals differ in their susceptibility to this condition.
Visits From Pharmaceutical Reps
January 1st 2001With new pharmaceuticals entering into the market, sales calls on psychiatrists rose 5% from October 1998 to October 1999. Increasingly, industry-supported dinners, meetings and educational activities are the norm, with physicians leading the lectures. Meanwhile, the reps often have useful information for the practicing clinician, such as new treatment options and how to dilute or split medications to make them easier to take or cost less.
Patient Privacy Battle Hinges on Competing Interests
January 1st 2001How much information do insurance companies need in order to reimburse psychiatrists? Should they be allowed access to therapy notes? These questions have sparked a battle in North Carolina that may affect the patient-psychiatrist relationship.